外周血miR-181a对慢性阻塞性肺疾病急性加重患者28d死亡的预测价值

王慧, 杨淼, 任慧敏, 等. 外周血miR-181a对慢性阻塞性肺疾病急性加重患者28d死亡的预测价值[J]. 临床急诊杂志, 2021, 22(11): 752-756. doi: 10.13201/j.issn.1009-5918.2021.11.010
引用本文: 王慧, 杨淼, 任慧敏, 等. 外周血miR-181a对慢性阻塞性肺疾病急性加重患者28d死亡的预测价值[J]. 临床急诊杂志, 2021, 22(11): 752-756. doi: 10.13201/j.issn.1009-5918.2021.11.010
WANG Hui, YANG Miao, REN Huimin, et al. Predictive value of miR-181a in peripheral blood on 28 day death in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. J Clin Emerg, 2021, 22(11): 752-756. doi: 10.13201/j.issn.1009-5918.2021.11.010
Citation: WANG Hui, YANG Miao, REN Huimin, et al. Predictive value of miR-181a in peripheral blood on 28 day death in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. J Clin Emerg, 2021, 22(11): 752-756. doi: 10.13201/j.issn.1009-5918.2021.11.010

外周血miR-181a对慢性阻塞性肺疾病急性加重患者28d死亡的预测价值

  • 基金项目:

    2019年度河北省医学科学研究课题计划(No:20190903)

详细信息
    通讯作者: 王慧,E-mail:wangh011@163.com
  • 中图分类号: R563.9

Predictive value of miR-181a in peripheral blood on 28 day death in patients with acute exacerbation of chronic obstructive pulmonary disease

More Information
  • 目的:研究外周血miR-181a对慢性阻塞性肺疾病急性加重患者(AECOPD)28 d死亡的预测价值。方法:选择2017年10月-2019年12月期间在我院住院治疗的AECOPD患者作为AECOPD组,同期在门诊就诊的稳定期COPD患者作为稳定期COPD组、体检的健康者作为对照组。检测外周血miR-181a的表达水平及血清肿瘤坏死因子-α(TNF-α)、IL-6、IL-8的含量。观察AECOPD患者的28 d死亡情况,采用ROC曲线分析miR-181a、TNF-α、IL-6、IL-8对28 d死亡的预测价值,采用Kaplan-Meier曲线分析miR-181a、TNF-α、IL-6、IL-8与28 d死亡的相关性,采用COX回归分析28 d死亡的影响因素。结果:AECOPD组患者外周血miR-181a的表达水平明显低于稳定期COPD组及对照组,血清TNF-α、IL-6、IL-8的含量明显高于稳定期COPD组及对照组(P<0.05)且miR-181a与TNF-α、IL-6、IL-8具有负相关关系;经ROC曲线分析,miR-181a、TNF-α、IL-6对AECOPD患者28 d死亡具有预测价值;经Kaplan-Meier曲线分析,AECOPD组中低miR-181a表达及高TNF-α、IL-6含量患者的28 d累积死亡率较高;经COX回归分析,miR-181a、TNF-α是AECOPD患者28 d死亡的影响因素。结论:AECOPD患者外周血miR-181a表达减少且与促炎因子释放及28 d累积死亡率增加有关,对28 d死亡具有预测价值。
  • 加载中
  • [1]

    Lindvig KP,Br⌀chner AC,Lassen AT,et al.Prehospital prognosis is difficult in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Scand J Trauma Resusc Emerg Med,2017,25(1):106.

    [2]

    Hu WP,Lhamo T,Liu D,et al.Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].COPD,2019,16(2):160-167.

    [3]

    Duan R,Niu H,Yu T,et al.Identification and Bioinformatic Analysis of Circular RNA Expression in Peripheral Blood Mononuclear Cells from Patients with Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2020,16(15):1391-1401.

    [4]

    Liu X,Qu J,Xue W,et al.Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD[J].Int J Chron Obstruct Pulmon Dis,2018,16(13):1217-1228.

    [5]

    Wang R,Xu J,Liu H,et al.Peripheral leukocyte microRNAs as novel biomarkers for COPD[J].Int J Chron Obstruct Pulmon Dis,2017,6(12):1101-1112.

    [6]

    粱珍珍,吕燕平,张艳莉,等.miR-181a参与调控香烟提取物诱导的NR8383肺泡巨噬细胞自噬紊乱与促炎因子的生成[J].中国病理生理杂志,2019,35(4):710-717.

    [7]

    Xie L,Wu M,Lin H,et al.An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers[J].Mol Biosyst,2014,10(5):1072-1081.

    [8]

    中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.

    [9]

    Son ES,Park JW,Kim YJ,et al.Effects of antioxidants on oxidative stress and inflammatory responses of human bronchial epithelial cells exposed to particulate matter and cigarette smoke extract[J].Toxicol In Vitro,2020,67:104883.

    [10]

    Shukla SD,Walters EH,Simpson JL,et al.Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease[J].Respirology,2020,25(1):53-63.

    [11]

    He B,Chen Q,Zhou D,et al.Role of reciprocal interaction between autophagy and endoplasmic reticulum stress in apoptosis of human bronchial epithelial cells induced by cigarette smoke extract[J].IUBMB Life,2019,71(1):66-80.

    [12]

    Zhang J,Bai C.The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease[J].Tanaffos,2018,17(1):13-21.

    [13]

    梁杨丽,毛兵.稳定期慢性阻塞性肺疾病患者血浆及诱导痰中炎性因子水平变化[J].中华实用诊断与治疗杂志,2018,32(11):1087-1090.

    [14]

    Huang X,Zhu Z,Guo X,et al.The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease[J].Int Immunopharmacol,2019,67:335-347.

    [15]

    Tan BWQ,Sim WL,Cheong JK,et al.MicroRNAs in chronic airway diseases:Clinical correlation and translational applications[J].Pharmacol Res,2020,23(160):105045.

    [16]

    Akhter S,Warraich UA,Ghazal S,et al.Assessment and comparison of APACHE Ⅱ(Acute Physiology and Chronic Health Evaluation),SOFA(Sequential Organ Failure Assessment)score and CURB 65(Confusion;Urea;Respiratory Rate;Blood Pressure),for prediction of inpatient death in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].J Pak Med Assoc,2019,69(2):211-215.

    [17]

    李娇,王宋平.慢性阻塞性肺疾病急性加重期患者预后的影响因素[J].中国老年学杂志,2019,39(12):2907-2910.

    [18]

    施继红,蒲爱华.慢性阻塞性肺疾病急性加重期患者近期预后的影响因素分析[J].中国慢性病预防与控制,2017,25(11):853-855.

    [19]

    赵佳,赵雅静,安艳春,等.慢性阻塞性肺疾病急性加重患者30d内不同预后的临床数据分析[J].临床急诊杂志,2020,21(1):65-69.

    [20]

    Park S,Lee SJ,Shin B,et al.The association of delta neutrophil index with the prognosis of acute exacerbation of chronic obstructive pulmonary disease[J].BMC Pulm Med,2020,20(1):47.

    [21]

    倪晓辉,朱萍,刘云杰,等.中性粒细胞CD64指数在预测慢性阻塞性肺疾病急性加重期患者预后中的临床价值[J].现代预防医学,2017,44(19):3636-3639,3644.

  • 加载中
计量
  • 文章访问数:  242
  • PDF下载数:  49
  • 施引文献:  0
出版历程
收稿日期:  2021-08-26

目录